Goodwin Procter advised Qilu Pharmaceutical on the deal. Qilu Pharmaceutical, one of the leading pharmaceutical companies in China (“Qilu”), announced its exclusive licensing agreement and strategic partnership...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Innovium on the deal. Innovium announced its acquisition by Marvell Technology (NASDAQ: MRVL) in an all-stock transaction, which closed on October 5, 2021. Under...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Pathwire on the deal, while K&L Gates and Gernandt & Danielsson advised Sinch AB. Pathwire, along with its private equity owner Thoma Bravo...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Elligo Health Research on the deal while Holland & Knight represented Morgan Stanley Expansion Capital and Ally Bridge Group. Elligo Health Research announced its...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Garuda Therapeutics on the deal. Garuda Therapeutics announced its launch and $72 million Series A financing led by Aisling Capital, Northpond Ventures, and OrbiMed,...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Hopin on the deal. Hopin, one of the fastest growing startups in Europe, completed its $450 million Series D funding round led by...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised EQRx on the deal while White & Case LLP advised CM Life Sciences III Inc. EQRx, Inc. announced its definitive merger agreement with CM...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Synaptics Incorporated on the deal while Morrison & Foerster represented DSP Group, Inc. Synaptics Incorporated (Nasdaq: SYNA) and DSP Group, Inc. (Nasdaq: DSPG)...
You must be a Standard 1 Year member to access this content.
Goodwin Procter and Kinstellar advised thredUP on the deal. Gugushev & Partners advised the Remix Global majority shareholders on the deal. ThredUp Inc. (NASDAQ: TDUP), one...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised RBC Bearings Incorporated on the deal, while Kirkland & Ellis advised ABB. RBC Bearings Incorporated (Nasdaq: ROLL) announced its definitive agreement to acquire the...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised the underwriters, while Latham & Watkins represented Rapid Micro Biosystems, Inc. in the offering. Rapid Micro Biosystems, Inc. (Nasdaq: RPID), an innovative life sciences...
You must be a Standard 1 Year member to access this content.
Paul Hastings advised 2U, Inc. on the deal while Goodwin Procter represented edX. 2U, Inc., a global leader in education technology, announced a definitive agreement to acquire...
You must be a Standard 1 Year member to access this content.
